Dietary protection against APOE4 phenotypes in aging and Alzheimer's
饮食对衰老和阿尔茨海默病中 APOE4 表型的保护作用
基本信息
- 批准号:10769123
- 负责人:
- 金额:$ 99.64万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-07-01 至 2028-03-31
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAgeAge-associated memory impairmentAgingAllelesAlzheimer&aposs DiseaseAlzheimer&aposs disease modelAlzheimer&aposs disease pathologyAlzheimer&aposs disease riskApolipoprotein EBrainDataDietDietary InterventionEnergy MetabolismEnvironmentExhibitsFastingFemaleGenesGenotypeGoalsHumanImpaired cognitionImpairmentIn SituInflammatoryInterventionKetonesLinkMetabolicMethionineMitochondriaMusN-formylmethionylphenylalanineNutritionalOutcomeOutcome MeasurePathogenesisPathologyPathway interactionsPeptidesPhenotypePreventionPropertyRegulationSex DifferencesShotgunsSignal PathwayTREM2 geneTestingTransgenesage relatedanti agingapolipoprotein E-3clinical translationcombatdesigndietarydietary controlefficacy testingglial activationimprovedimproved outcomein vitro Modellipid metabolismlipidomicsmalemetabolic fitnessmiddle agemortalitymouse modelneuralnovelnutritional approachpre-clinicalpreventsextranscriptomics
项目摘要
The ɛ4 allele of apolipoprotein E (APOE4) is associated with accelerated aging and mortality as well increased vulnerability to Alzheimer’s disease (AD). Although the causal links between APOE4, aging, and AD risk remain to be fully defined, candidate mechanisms include regulation of energy metabolism and systemic and neural inflammatory tone. Our recent findings demonstrate that nutritional approaches, including fasting mimicking diet (FMD), exhibit anti-aging and protective properties across several age-related conditions. Indeed, pathways identified to be beneficially regulated by FMD and related nutritional interventions overlap with pathways thought to underlie relationships among APOE4, aging, and AD. In this project, we investigate the central hypothesis that the dietary intervention FMD will protect against APOE4 phenotypes that drive age-related cognitive impairment and AD pathogenesis. We will investigate this hypothesis by studying systemic and neural effects of FMD and related dietary interventions across age in mice with human APOE genotypes both in the absence and presence of AD transgenes. Our studies will interrogate several potential mechanisms hypothesized to underlie gene X environment relationships between APOE and diet with emphases on brain energy metabolism and regulation of microglial activation profiles. We propose three aims. Aim 1: Do dietary interventions protects against APOE4-associated aging phenotypes? We test the hypothesis that nutritional interventions will improve systemic and neural outcomes in the contexts of aging and APOE4 genotype. Studies will test the ability of diet to prevent vs treat APOE4-associated phenotypes. We will test the efficacy of low methionine or high ketone diets assess the hypothesized abilities of a fasting-mimicking mitochondrial-derived peptide to mirror protective actions of FMB across APOE genotype. Aim 2: Do dietary interventions provide protection against Alzheimer pathology in an APOE-dependent manner? The second aim is conceptually parallel to Aim 1 but with a focus on diet and APOE genotype in the context of AD pathology. These studies will be conducted in male and female APOE3 vs APOE4 AD mice to determine potential sex differences and at two different ages to consider efficacies for both the prevention and treatment. Aim 3: Do dietary interventions improve glial phenotypes associated with again, APOE4, and AD? We investigate the hypothesis that the primary mechanism by which dietary interventions protect against APOE4 phenotypes is improvement in glial transcriptomic profiles and functions. We will interrogate the hypothesis that a key regulator of APOE-dependent differences is the TREM2-ApoE signaling pathway, which is linked to AD risk via actions on microglial phenotype and metabolic fitness. Completion of the proposed studies will yield preclinical data that define the interactions and underlying mechanisms among diet, APOE genotype, sex, age, and intervention timing, relationships that are essential to the effective clinical translation of dietary strategies to combat cognitive decline and AD.
载脂蛋白E (APOE4)的等位基因与加速衰老和死亡率以及阿尔茨海默病(AD)易感性增加有关。尽管APOE4、衰老和AD风险之间的因果关系尚未完全确定,但候选机制包括能量代谢调节和全身和神经炎症张力。我们最近的研究结果表明,营养方法,包括禁食模拟饮食(FMD),在几种与年龄相关的疾病中表现出抗衰老和保护特性。事实上,口蹄疫和相关营养干预所确定的有益调节通路与APOE4、衰老和AD之间关系的通路重叠。在本项目中,我们研究了饮食干预FMD将保护APOE4表型的中心假设,APOE4表型驱动年龄相关的认知障碍和AD发病机制。我们将通过研究人类APOE基因型小鼠在没有和存在AD转基因的情况下,口蹄疫和相关饮食干预对整个年龄的系统和神经的影响来研究这一假设。我们的研究将探究APOE与饮食之间的基因X环境关系的几种潜在机制,重点关注大脑能量代谢和小胶质细胞激活谱的调节。我们提出了三个目标。目标1:饮食干预是否可以预防apoe4相关的衰老表型?我们测试了营养干预将改善衰老和APOE4基因型背景下的系统和神经结果的假设。研究将测试饮食预防和治疗apoe4相关表型的能力。我们将测试低蛋氨酸或高酮饮食的功效,评估模拟禁食的线粒体衍生肽在APOE基因型中反映FMB保护作用的假设能力。目标2:饮食干预是否以apoe依赖的方式提供对阿尔茨海默病的保护?第二个目标在概念上与目标1相似,但重点关注AD病理背景下的饮食和APOE基因型。这些研究将在雄性和雌性APOE3与APOE4 AD小鼠中进行,以确定潜在的性别差异,并在两个不同的年龄进行研究,以考虑预防和治疗的效果。目标3:饮食干预是否能改善与APOE4和AD相关的神经胶质表型?我们研究了一种假设,即饮食干预保护APOE4表型的主要机制是改善神经胶质转录组谱和功能。我们将质疑apoe依赖性差异的关键调节因子是TREM2-ApoE信号通路的假设,该信号通路通过对小胶质细胞表型和代谢适应性的作用与AD风险相关。这些研究的完成将产生临床前数据,以确定饮食、APOE基因型、性别、年龄和干预时间之间的相互作用和潜在机制,这些关系对于有效临床转化饮食策略以对抗认知能力下降和AD至关重要。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CHRISTIAN J PIKE其他文献
CHRISTIAN J PIKE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CHRISTIAN J PIKE', 18)}}的其他基金
Interactions between Testosterone and Type 2 Diabetes in Alzheimer's Disease
睾酮与 2 型糖尿病在阿尔茨海默病中的相互作用
- 批准号:
8325047 - 财政年份:2011
- 资助金额:
$ 99.64万 - 项目类别:
Interactions between Testosterone and Type 2 Diabetes in Alzheimer's Disease
睾酮与 2 型糖尿病在阿尔茨海默病中的相互作用
- 批准号:
8717547 - 财政年份:2011
- 资助金额:
$ 99.64万 - 项目类别:
Interactions between Testosterone and Type 2 Diabetes in Alzheimer's Disease Path
睾酮与 2 型糖尿病在阿尔茨海默氏病路径中的相互作用
- 批准号:
8188180 - 财政年份:2011
- 资助金额:
$ 99.64万 - 项目类别:
Interactions between Testosterone and Type 2 Diabetes in Alzheimer's Disease
睾酮与 2 型糖尿病在阿尔茨海默病中的相互作用
- 批准号:
8526318 - 财政年份:2011
- 资助金额:
$ 99.64万 - 项目类别:
Perimenopause in APOE4 Brain: Obesity and Alzheimer's Pathobiology
APOE4 大脑的围绝经期:肥胖和阿尔茨海默病病理学
- 批准号:
9354255 - 财政年份:2006
- 资助金额:
$ 99.64万 - 项目类别:
Perimenopause in APOE4 Brain: Obesity and Alzheimer's Pathobiology
APOE4 大脑的围绝经期:肥胖和阿尔茨海默病病理学
- 批准号:
9074569 - 财政年份:2006
- 资助金额:
$ 99.64万 - 项目类别:
PROGESTERONE REGULATION OF ALZHEIMER'S RELATED PATHOLOGY
黄体酮对阿尔茨海默病相关病理的调节
- 批准号:
7082607 - 财政年份:2006
- 资助金额:
$ 99.64万 - 项目类别:
PERIMENOPAUSE, OVARIAN HORMONES, AND OBESITY: INTERACTIVE REGULATORS OF ALZHEIMER
围绝经期、卵巢激素和肥胖:阿尔茨海默病的交互式调节因子
- 批准号:
8231929 - 财政年份:2006
- 资助金额:
$ 99.64万 - 项目类别:
相似国自然基金
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
- 批准号:JCZRQN202500010
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
- 批准号:2025JJ70209
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
- 批准号:
- 批准年份:2024
- 资助金额:0 万元
- 项目类别:面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
- 批准号:2023JJ50274
- 批准年份:2023
- 资助金额:0.0 万元
- 项目类别:省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
- 批准号:n/a
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
- 批准号:81973577
- 批准年份:2019
- 资助金额:55.0 万元
- 项目类别:面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
- 批准号:81602908
- 批准年份:2016
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
- 批准号:81501928
- 批准年份:2015
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
相似海外基金
THE GENETICS AND FUNCTIONAL NEUROANATOMY OF AGE-ASSOCIATED MEMORY IMPAIRMENT
年龄相关记忆障碍的遗传学和功能神经解剖学
- 批准号:
7606738 - 财政年份:2007
- 资助金额:
$ 99.64万 - 项目类别:
THE GENETICS AND FUNCTIONAL NEUROANATOMY OF AGE-ASSOCIATED MEMORY IMPAIRMENT
年龄相关记忆障碍的遗传学和功能神经解剖学
- 批准号:
7717960 - 财政年份:2007
- 资助金额:
$ 99.64万 - 项目类别:
THE GENETICS AND FUNCTIONAL NEUROANATOMY OF AGE-ASSOCIATED MEMORY IMPAIRMENT
年龄相关记忆障碍的遗传学和功能神经解剖学
- 批准号:
7205360 - 财政年份:2004
- 资助金额:
$ 99.64万 - 项目类别:
CITICOLINE AND AGE ASSOCIATED MEMORY IMPAIRMENT
胞二磷胆碱与年龄相关的记忆障碍
- 批准号:
6305687 - 财政年份:1999
- 资助金额:
$ 99.64万 - 项目类别:
CITICOLINE AND AGE ASSOCIATED MEMORY IMPAIRMENT
胞二磷胆碱与年龄相关的记忆障碍
- 批准号:
6115572 - 财政年份:1998
- 资助金额:
$ 99.64万 - 项目类别:
A study on the biological features of age-associated memory impairment (AAMI).
年龄相关记忆障碍(AAMI)生物学特征的研究。
- 批准号:
09671003 - 财政年份:1997
- 资助金额:
$ 99.64万 - 项目类别:
Grant-in-Aid for Scientific Research (C).
CITICOLINE AND AGE ASSOCIATED MEMORY IMPAIRMENT
胞二磷胆碱与年龄相关的记忆障碍
- 批准号:
6276806 - 财政年份:1997
- 资助金额:
$ 99.64万 - 项目类别:
AGE-ASSOCIATED MEMORY IMPAIRMENT: COMMUNITY-BASED STUDY
与年龄相关的记忆障碍:基于社区的研究
- 批准号:
3386469 - 财政年份:1990
- 资助金额:
$ 99.64万 - 项目类别:
AGE-ASSOCIATED MEMORY IMPAIRMENT: COMMUNITY-BASED STUDY
与年龄相关的记忆障碍:基于社区的研究
- 批准号:
3386468 - 财政年份:1990
- 资助金额:
$ 99.64万 - 项目类别:
AGE-ASSOCIATED MEMORY IMPAIRMENT: COMMUNITY-BASED STUDY
与年龄相关的记忆障碍:基于社区的研究
- 批准号:
2247160 - 财政年份:1990
- 资助金额:
$ 99.64万 - 项目类别: